The Czech entertainment industry is rallying around television presenter Laďka Něrgešová, who is courageously battling glioblastoma, an aggressive form of brain cancer. After undergoing surgery, chemotherapy, and radiation treatment, Něrgešová has returned to television, demonstrating remarkable resilience and a commitment to raising awareness about the disease.
Něrgešová publicly disclosed her diagnosis in July 2025, explaining her absence from the screen to viewers of Prima TV. The revelation followed an emergency operation performed by Dr. Dávid Netuka at the Central Military Hospital, where the tumor was removed. While glioblastoma is notoriously difficult to treat, with a low five-year survival rate, Něrgešová has embraced modern medical approaches and continues to inspire with her positive outlook.
The presenter’s return to hosting the show Showtime in September 2025 marked a significant moment, not only for her personally but also for her audience. She acknowledged her anxieties about resuming her career after such a major medical intervention, stating, “It’s probably strange what I’m going to say, but I’m really scared, because when they take out such a large piece of your brain, I feel like I won’t be able to cope.” Despite these concerns, she expressed gratitude to Prima TV for their support and patience.
Něrgešová has been open about the physical effects of her treatment, notably appearing on air without a wig, revealing the scar from her surgery and the hair loss caused by chemotherapy. This act of vulnerability has resonated deeply with the public, challenging societal norms surrounding illness and beauty standards. She has also been undergoing a treatment known as TTFields, which involves wearing electrodes on the scalp to disrupt the growth of cancer cells.
Glioblastoma is a rare but highly aggressive brain tumor characterized by rapid growth and infiltration into surrounding brain tissue. According to the Cleveland Clinic, common symptoms include vision changes, memory problems, headaches, and seizures. While the exact cause remains unknown, treatment typically involves surgery, radiation therapy, and chemotherapy. The prognosis for patients with glioblastoma remains challenging, with a median survival time of 12 to 18 months, although a small percentage of patients survive for five years or longer.
Něrgešová’s decision to share her journey publicly has been praised by psychologists, who highlight the therapeutic benefits of openness and authenticity. Psychologist Jan Beer noted that her willingness to discuss her fears and hopes, and to show the realities of her treatment, is a powerful coping mechanism and can inspire others facing similar challenges. “Fixation on the future is incredibly important. It is a truly strong engine for the regeneration of the entire organism,” Beer stated.
As of February 7, 2026, Něrgešová continues to work and remains optimistic, despite acknowledging the ongoing nature of her battle. She recently celebrated her 50th birthday, expressing gratitude for the support of her family, friends, and medical team. Her message on social media, “I wish there would be a miracle, and I could stay here for a few more months… years? For MY CHILDREN!” underscores her determination to live life to the fullest and to continue inspiring others.
Něrgešová’s story is a testament to the power of resilience, the importance of open communication about health challenges, and the advancements being made in the treatment of glioblastoma. Her courage and honesty are providing hope and support to countless individuals and families affected by this devastating disease.
